Navigation Links
Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
Date:4/19/2010

Preclinical research takes a giant step forward with two industry leading companies creating an integration breakthrough with toxicology software and study-scaled capsule filling device.

Greifensee, Zurich (PRWEB) April 19, 2010 -- The world-class preclinical software developer PDS Pathology Data System (PDS) and METTLER TOLEDO (MT), global manufacturer of weighing technology, announce a cooperative initiative to improve the security and accuracy of preclinical processes. The result of the collaboration is an integration of the powerful MT powder dosing system, Quantos and the PDS mission-critical software system, ToxData. The solution will provide significant efficiencies while increasing data security and assuring full regulatory compliance.

In making this historic announcement, Matthias Gietenbruch, Head of Automated Weighing and Dosing of MT explained, “Bringing the integration of Quantos and ToxData together in the preclinical laboratory is truly a landmark for efficiency and accuracy. We are pleased to forging this alliance with PDS. They have distinguished themselves as being customer-focused and leaders in innovative preclinical software solutions."

Reto Aerni, CEO of PDS, commented, “PDS has always taken pride in raising the bar in the preclinical space. The opportunity to work with METTLER TOLEDO in such an innovative project and provide our mutual customers a synergistic value that is simply unavailable anywhere else is exciting and representative of the best that both our companies stand for."

Quantos is a novel powder dosing system that provides unprecedented dose filling speed and accuracy in the preclinical lab. ToxData is a leading protocol-driven software system used for acquiring, measuring and reporting preclinical study data. Through the interface of the two systems, accurate work lists are sent to the dosing system and dose preparations
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Process Safety and Thermal Hazard Analysis Fall Webinar Series presented by METTLER TOLEDO
2. Maximize Data Analysis with METTLER TOLEDO FBRM
3. METTLER TOLEDO and AAPS: Utilization of Process Modeling and Advanced Process Control in QbD based Drug Development and Manufacturing
4. METTLER TOLEDO Introduces an Affordable Reaction Block for Solid Phase Peptide Synthesis (SPPS)
5. Martin Madaus Joins Mettler Toledo Board of Directors
6. IMPAC Medical Systems and Aperio to Develop Integrated Solution for Anatomic Pathology
7. Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner
8. ARUP Laboratories Partners With Pathology Service Associates
9. Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc.
10. James L. Wittliff, Ph.D., FACB, to Present Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System at the Association for Molecular Pathology Conference, October 30
11. Cancer, Heart Disease, Stroke, Diabetes, Chronic Pain and Depression Share a Major Pathology Factor
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
(Date:3/25/2015)... Francisco, CA (PRWEB) March 25, 2015 ... Support for Novel Mechanism of Action in Neuromuscular ... 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced ... fast skeletal muscle troponin activator tirasemtiv in the ... a Phase IIa “Evidence of Effect” or hypothesis-generating ...
(Date:3/25/2015)... and the HAGUE, Netherlands , March ... of LES Stimulation therapy for chronic gastro-esophageal reflux disease ... Surgery [ Surgery . 2015; 157(3):556-567 ], ... minimally-invasive therapy. The study included 25 ... 11 years and taking prescribed daily proton pump inhibitor ...
(Date:3/25/2015)... COLLEGE PARK, Md. , March 25, 2015 ... of two years of intense research by scientists ... University of Maryland and represent a breakthrough in ... an assistant professor in the Department of Animal & ... faculty research assistant in ANSC, successfully produced genome-edited ...
(Date:3/25/2015)... , March 25, 2015  CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... 2 trial of its target therapy drug candidate ENMD-2076 ... of Chinese Academy of Medical Sciences in ...
Breaking Biology Technology:Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 2CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 3CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 4CASI Pharmaceuticals Announces Initiation Of A Phase 2 Trial With ENMD-2076 In Triple-Negative Breast Cancer In China 5
... Informed Medical Communications (IMC), a leading provider of ... announced the appointment of Kerry Crawford to the ... this critical role, Kerry will lead operations and ... relationship management systems. This key addition is ...
... sweeteners partner to produce world,s first probiotic-enhanced ... baking aisleINDIANAPOLIS, March 3 Ganeden ... the patented probiotic strain GanedenBC30, today announced ... , an Indianapolis-based leading innovator of health ...
... Inc.,(OTC Bulletin Board: CLXS), a leading developer of ... launch of the world,s first,CTSA Experts Platform drawing ... more than 60,000 life science researchers. The platform ... of the Clinical Translational Science,Awards (CTSA,s) from the ...
Cached Biology Technology:Informed Medical Communications Appoints New Senior Manager, Strategic Operations 2Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 2Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 3Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 2Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 3
(Date:3/11/2015)... and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) has announced ... Product, Application & By Geography - Global Forecast & ... This report predicts that the access control ... with an estimated CAGR of 10.6%. The ... as contact cards & readers, contactless cards & readers, ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
(Date:3/10/2015)... Utah , March 10, 2015   Tute ... interpretation, has been selected by next-generation sequencing company ... of whole exome and targeted gene panel interpretation. ... provider, has adopted the most current technologies to support ... genetic research. The company offers two types of exome ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... will gather in Maputo, Mozambique, 21-24 October, for the ... Science (ICSU)the first time an ICSU GA will be ... scientists from around the world will come together at ... can contribute to solving some of the most pressing ...
... green may be heart healthy if the green ... at Penn State who conducted the first study ... "We investigated mechanisms of action to explain the ... K. Gebauer, recent Penn State Ph.D. recipient, currently ...
... Boulder, CO, USA Counting on wetlands restoration projects ... is likely to be a "losing battle" that provides ... for their future, says a researcher from Western Carolina ... Gulf of Mexico this fall, the media has been ...
Cached Biology News:Global science community to gather in Mozambique 2Researchers study how pistachios may improve heart health 2Wetlands restoration not a panacea for Louisiana coast 2Wetlands restoration not a panacea for Louisiana coast 3
Human peripheral blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Human plasmacytoid dendritic cells, BDCA-4+, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Biology Products: